- Home
- CCCX vs STAA Comparison
CCCX vs STAA Comparison
Compare CCCX & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$19.25
Company Overview
Basic Information| Metric | CCCX | STAA |
|---|---|---|
| Founded | 2024 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 904.1M | 1.0B |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | CCCX | STAA |
|---|---|---|
| Price | $17.08 | $19.25 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $23.47 |
| AVG Volume (30 Days) | ★ 1.8M | 1.6M |
| Earning Date | 01-01-0001 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $230,591,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $21.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.03 | $13.50 |
| 52 Week High | $27.50 | $30.81 |
Technical Indicators
Market Signals| Indicator | CCCX | STAA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 27.71 |
| Support Level | N/A | $19.40 |
| Resistance Level | N/A | $21.27 |
| Average True Range (ATR) | 0.00 | 1.20 |
| MACD | 0.00 | -0.20 |
| Stochastic Oscillator | 0.00 | 2.31 |
Price Performance
Historical Comparison CCCX
STAA
About CCCX Churchill Capital Corp X Class A Ordinary Shares
Churchill Capital Corp X is a blank check company.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.